Lymphoma Group

The NCRI Lymphoma Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of lymphoma. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for lymphoma patients.  

The NCRI Lymphoma Group consists of an executive group, chaired by Professor Andrew Pettitt, which provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Lymphoma Group also has several subgroups that develop research in areas of strategic need. 

Members are competitively recruited to the executive Group and subgroups twice a year and are advertised on the jobs and opportunities page. If there are not currently any vacancies, you are encouraged to register your interest via email.

Group Chair: Professor Andrew Pettitt

Shamzah Araf, Haematology Registrar, Barts Health NHS Trust

Arzhang Ardavan, NCRI Consumer Forum member, Professor of physics

Pauline Boyle, King’s College London (KCL)

Sridhar Chaganti, Consultant Haematologist, Queen Elizabeth Hospital Birmingham

Stavroula Chante, Nurse, Queen Elizabeth Hospital Birmingham

Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)

Graham Collins, Oxford University Hospitals NHS Foundation Trust

Richard A Cowan, Consultant/Director of Education, Christie NHS Foundation Trust

Thomas Cummin, Clinical Research Fellow/ Specialist Registrar Haematology, University of Southampton

David Cutter, Consultant Clinical Oncologist and Clinical Research Fellow, Oxford University Hospitals NHS Foundation Trust

Caroline Dalton, Research Programme Manager, Cancer Research UK (CRUK)

Paul Fields, Consultant Haematologist, Guy’s and St Thomas’ NHS Foundation Trust

Jude Fitzgibbon, Professor of Personalised Cancer Medicine, Queen Mary University of London

Christopher Fox, Consultant Haematologist, Nottingham University Hospitals NHS Trust

Daniel Hodson, Honorary Consultant Haematologist, University of Cambridge

Karen Hylton, Acting Research Delivery Manager, NIHR Division 1, NIHR Clinical Research Network – West Midlands

Tim Illidge, Clinical Oncologist Professor of Targeted Therapy & Oncology, Head of Division of Cancer Sciences, University of Manchester

Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester

Pam McKay, NHS Greater Glasgow and Clyde

Andrew McMillan, Consultant Haematologist, Nottingham University Hospitals NHS Trust

Tobias Menne, Newcastle upon Tyne Hospitals NHS Foundation Trust

Geetha Menon, Haematopathologist, Liverpool University Hospitals NHS Foundation Trust

Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust

Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool

Beth Phillips, Lymphoma Clinical Trials Fellow, University College London (UCL)

Dr John Riches, Clincial Scientist, Barts and The London School of Medicine and Dentistry

Katharine Robinson, NCRI Consumer Forum member

Stephen Scowcroft, Head of Business Development, Lymphoma Action

Emma Searle, Clinical Lecturer and Honorary Consultant Haematologist, University of Manchester

Louise Stanton, Principal Medical Statistician, University of Southampton

Fatima Sulaiman, Head of Research, Blood Cancer UK

Victoria Warbey, PET Imaging/Radiology, NHS Greater Glasgow and Clyde

More from NCRI